Real-world (RW) study in patients (pts) with metastatic colorectal cancer (mCRC) with long-term responses to regorafenib in the USA.

被引：0
|
作者：
Kim, Richard D.
Pan, Xiaoyun
Ostojic, Helene
Zhang, Yiqiao
Lunacsek, Orsolya
Pisa, Federica
Peeters, Marc
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Bayer HealthCare Pharmaceut Inc, Real World Evidence Oncol, Whippany, NJ USA
[3] Bayer Consumer Care AG, Basel, Switzerland
[4] Bayer HealthCare Pharmaceut, Whippany, NJ USA
[5] Bayer AG, Real World Evidence Oncol, Berlin, Germany
[6] Antwerp Univ, Antwerp Univ Hosp, Edegem, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
281-5277-2622-5397; 281-318-9499; 283-237-255; 3282-206-4957-326-5009-2386; 4; 3; 2; 182; 250; 38092-25821; 38092-20285; 38092-18849;
D O I：
10.1200/JCO.2024.42.3_suppl.48
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [11] Long-term response to regorafenib (REG) in patients with metastatic colorectal cancer (mCRC): A systematic literature review (SLR)
    Peeters, M.
    Pan, X.
    Koufopoulou, M.
    Arregui, M.
    Wissinger, E.
    Ostojic, H.
    Pisa, F.
    Kim, R. D.
    ANNALS OF ONCOLOGY, 2024, 35 : S30 - S31
  • [12] Real-world effectiveness of regorafenib in the treatment of patients with metastatic colorectal cancer: A retrospective, observational study
    Wang, Hailing
    Liu, Weiling
    Zhao, Yan
    Hu, Hongtao
    Zhang, Bin
    Yang, Shujun
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (05) : E291 - E299
  • [13] Real-world dosing of regorafenib (REG) in metastatic colorectal cancer (mCRC): Final results from the prospective, observational CORRELATE study
    O'Connor, J. M.
    Ducreux, M.
    Petersen, L. N.
    Oehler, L.
    Bergamo, F.
    Metges, J-P.
    de Groot, J. W.
    Wang, J-Y.
    Garcia Paredes, B.
    Dochy, E.
    Fiala-Buskies, S.
    Cervantes, A.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [14] Long-term clinical outcomes after the second metastasectomy in patients (pts) with resected metastatic colorectal cancer (mCRC)
    Choi, S.
    Kang, M.
    Kim, J-W.
    Kim, J. W.
    Hwang, Y.
    Jeon, J. H.
    Oh, H-K.
    Lee, H. W.
    Cho, J. Y.
    Kim, D-W.
    Cho, S.
    Kim, J. H.
    Kim, K.
    Kang, S-B.
    Jheon, S.
    Lee, K-W.
    ANNALS OF ONCOLOGY, 2022, 33 : S1447 - S1447
  • [15] Outcomes of long responders chemorefractory metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib: a single institution experience
    Sforza, V.
    Capasso, A.
    Nappi, A.
    Cardone, C.
    Martini, G.
    Ferrara, M. L.
    Napolitano, S.
    Vitiello, P.
    Vitale, P.
    Zanaletti, N.
    De Vita, F.
    Orditura, M.
    Troiani, T.
    Ciardiello, F.
    Martinelli, E.
    ANNALS OF ONCOLOGY, 2016, 27
  • [16] Real-World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib
    Patel, Anuj K.
    Barghout, Victoria
    Yenikomshian, Mihran A.
    Germain, Guillaume
    Jacques, Philippe
    Laliberte, Francois
    Duh, Mei S.
    ONCOLOGIST, 2020, 25 (01): : E75 - E84
  • [17] Regorafenib in patients with metastatic colorectal cancer in Spain: from clinical trials to real-world evidence
    Cervantes, Andres
    Tabernero, Josep
    Garcia-Carbonero, Rocio
    Sastre, Javier
    Feliu, Jaime
    Guillen-Ponceg, Carmen
    Paredes, Beatriz Garcia
    Carral, Alberto
    Munoz, Jorge
    FUTURE ONCOLOGY, 2024, 20 (20) : 1401 - 1413
  • [18] A multiple centers real-world study of regorafenib treatment modalities in Chinese metastatic colorectal cancer patients.
    Li, Xia Fen
    Luo, Huiyan
    Wang, Zhiqiang
    Xiao, Jian
    Peng, Jianjun
    Wang, Zi-xian
    Zhai, Xiaohui
    Xu, Rui-hua
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15543 - E15543
  • [19] Real-world dosing patterns of regorafenib in patients with metastatic colorectal cancer in Spain: The RE-SEARCH study
    Lopez Munoz, A.
    Gonzalez-Flores, E.
    Afonso, R.
    Carral Maseda, A.
    Pimentel, P.
    Lopez-Lopez, C.
    Jimeno, R.
    Fuentes Mateos, R.
    Reina Zoilo, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S14 - S15
  • [20] Results of a retrospective multicenter study comparing the effectiveness of regorafenib and the rechallenge of chemotherapy in patients (pts) with metastatic colorectal cancer (mCRC)
    Kuzmina, Evgenia
    Fedyanin, Mikhail
    Reshetov, Igor
    Parts, Sergey
    Pokataev, Ilya
    Polyanskiy, Maxim
    Antonova, Tatiana
    Pikulin, Dmirii
    Arseneva, Evgenia
    Anikina, Marina
    Golubev, Pavel
    Syskova, Anna
    Galkin, Vsevolod
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345